drugset / Trial / NCT07530640
Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The goal of this observational study is to learn about the safety and effects of atorvastatin in treatment of Chinese Kawasaki disease (KD) children complicated with coronary artery abnormalities (CAA) in acute phase. The main questions it aims to answer are: Is atorvastatin safe in Chinese children of acute KD? Does atorvastatin contribute to control the acute inflammation in KD and improve the CAA?
Timeline
- Start
- 2026-06-08
- Primary completion
- 2027-08-31
- Completion
- 2027-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 0.15 mg/kg | — |
| Subject | Atorvastatin | Small molecule | 0.25 mg/kg | — |
| Subject | Atorvastatin | Small molecule | 0.4 mg/kg | — |